Vesleteplirsen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vesleteplirsen, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen) [Phase 1, Phase 2]